Herbas VPB

Print
EN | LT
LT - E selektino antagonisto junginiai
EN - E-SELECTIN ANTAGONIST COMPOUNDS

Legal status

Patent lapsed (non-payment of fees)

Bibliographic data
Indications of the International Patent Classification (IPC)
(51) INT.CL. C07H 15/207 (2006.01)
A61K 31/7034 (2006.01)
A61P 35/00 (2006.01)
European patent
(11) Number of the document 2794626
(13) Kind of document T
(96) European patent application number 12813711.4
Date of filing the European patent application 2012-12-21
(97) Date of publication of the European application 2014-10-29
(45) Date of publication and mention of the grant of the patent 2017-11-01
(46) Date of publication of the claims translation 2018-02-12
PCT application
(86) Number PCT/US2012/071519
Date 2012-12-21
PCT application publication
(87) Number WO 2013/096926
Date 2013-06-27
Priority applications
(30) Number Date Country code
201161579646 P 2011-12-22 US
201261583547 P 2012-01-05 US
201261704399 P 2012-09-21 US
201261704424 P 2012-09-21 US
201261734924 P 2012-12-07 US
Inventors
(72)
MAGNANI, John, L., US
SARKAR, Arun, K., US
BAEK, Myung-Gi, US
ANDERSON, Frank, E., III, US
LI, Yanhong, US
Grantee
(73) GlycoMimetics, Inc., 9708 Medical Center Drive, Rockville, MD 20850, US
Attorney or representative
(74) Reda ŽABOLIENĖ, METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius, LT
Title
(54) E selektino antagonisto junginiai
  E-SELECTIN ANTAGONIST COMPOUNDS
Last renewal fee
Payment date Validity (years) Amount
2023-12-04 12 289.00 EUR
Legal status
Patent lapsed (non-payment of fees)
Invalidation date 2024-12-21